![Anthony Giovinazzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Giovinazzo
Président chez
XORTX THERAPEUTICS INC.
Fortune : 5 995 $ au 31/05/2026
Profil
Anthony J.
Giovinazzo was the founder of Cervelo Pharmaceuticals Ltd., founded in 2006, where the title held was Chief Executive Officer from 2006 to 2009.
Current jobs include Executive Chairman at Kalgene Pharmaceuticals, Inc. since 2021; Non-Executive Chairman at XORTX Therapeutics, Inc. since 2022; Director at COSCIENS Biopharma, Inc. since 2025; Director at Valo Therapeutics Oy since 2022; Director at Conavi Medical Corp.
since 2024; and Member at the Institute of Corporate Directors.
Former jobs include President & Chief Executive Officer at Sunovion CNS Development Canada Ulc; President, Chief Executive Officer & Director at Cynapsus Therapeutics, Inc. from 2009 to 2017; President & Chief Executive Officer at Cita NeuroPharmaceuticals, Inc. from 2002 to 2006; Executive Chairman at Sublimity Therapeutics Ltd. and Alpha Cognition, Inc.; Independent Director at Windfall Geotek, Inc. from 2012 to 2013; Director at ZyVersa Therapeutics Operating, Inc.; Director at Pond Technologies Holdings, Inc. from 2020 to 2021; Independent Director at ProMIS Neurosciences, Inc. from 2017 to 2020; Independent Director at Microbix Biosystems, Inc. from 2020 to 2022; Independent Director at Titan Medical, Inc. from 2020 to 2021; Venture Partner at Nordion (Canada), Inc.; President at PNO Resources Ltd., Neurotrophic Bioscience, Inc., and Nova Molecular, Inc. Education includes an undergraduate degree from McMaster University conferred in 1978 and an MBA from the International Institute for Management Development conferred in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/03/2026 | 1 925 ( 0,14% ) | 4 428 $ | 31/05/2026 | |
0,01% | 17/02/2026 | 8 473 ( 0,01% ) | 1 568 $ | 31/05/2026 |
Postes actifs de Anthony Giovinazzo
| Sociétés | Poste | Début |
|---|---|---|
| XORTX THERAPEUTICS INC. | Président | 03/06/2022 |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Develops novel immunotherapies for cancer and infectious disease | Directeur/Membre du Conseil | 27/06/2022 |
Kalgene Pharmaceuticals, Inc.
 Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and focuses on personalized cancer diagnostics | Président | 01/07/2021 |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | 13/09/2010 |
Anciens postes connus de Anthony Giovinazzo
| Sociétés | Poste | Fin |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Directeur/Membre du Conseil | 01/03/2022 |
| POND TECHNOLOGIES HOLDINGS INC. | Directeur/Membre du Conseil | 01/06/2021 |
| PROMIS NEUROSCIENCES, INC. | Directeur/Membre du Conseil | 01/09/2020 |
| CYNAPSUS THERAPEUTICS INC | Directeur Général | 01/03/2017 |
| WINDFALL GEOTEK INC. | Directeur/Membre du Conseil | 28/06/2013 |
Formation de Anthony Giovinazzo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Medical SpecialtiesHealth Technology Provides cobalt-60 and gamma irradiation system services for the medical device, food safety & health care industries | Health Technology |
Microbix Biosystems, Inc.
 Microbix Biosystems, Inc. BiotechnologyHealth Technology Develops biological products and technologies | Health Technology |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals Engages in the acquisition and exploration of natural resource properties | Non-Energy Minerals |
Windfall Geotek, Inc.
 Windfall Geotek, Inc. Precious MetalsNon-Energy Minerals Acquires, explores and develops mineral resource properties | Non-Energy Minerals |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule drugs | Health Technology |
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Neurotrophic Bioscience, Inc.
 Neurotrophic Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Nova Molecular, Inc.
 Nova Molecular, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical products | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Corporate Directors
Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Cervelo Pharmaceuticals Ltd.
 Cervelo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the preparation of pharmaceuticals | Health Technology |
Titan Medical, Inc.
 Titan Medical, Inc. Medical SpecialtiesHealth Technology Designs and develops robotic surgical technologies | Health Technology |
Sublimity Therapeutics Ltd.
 Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Kalgene Pharmaceuticals, Inc.
Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and focuses on personalized cancer diagnostics | Health Services |
Sunovion CNS Development Canada Ulc
 Sunovion CNS Development Canada Ulc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Health Technology |
Pond Technologies Holdings, Inc.
 Pond Technologies Holdings, Inc. Pharmaceuticals: OtherHealth Technology Engages in production and sale of nutraceutical and related products to business and retail customers | Health Technology |
XORTX Therapeutics, Inc.
 XORTX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Alpha Cognition, Inc. /old/
 Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treating alzheimer disease and amyotrophic lateral sclerosis | Health Technology |
Valo Therapeutics Oy
Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Develops novel immunotherapies for cancer and infectious disease | Health Technology |
